Home Diagnostics Inc.

Fort Lauderdale, Fla. • (954) 677-9201 • www.homediagnosticsinc.com

Exchange and Ticker: Nasdaq: HDIX

Filing Range: 3.3M shares @ $14 to $16

Offering Price: $12

Close on First Day: $12.60

Offering Size: $79.2M

Shares Outstanding: 17.58M

Underwriter: JP Morgan

Co-managers: Deutsche Bank Securities Corp./ William Blair & Co.

Company Counsel: Satterlee, Stephens, Burke & Burke

Manager Counsel: Cahill Gordon & Reindel

Auditor: Pricewaterhouse Coopers LLP

Market Capitalization on 9/30/06: $230.1M

Close price at current month end: $13.10

Company Description

Home Diagnostics manufactures medical diagnostic products. It provides diabetes products to retail pharmacy, mail service home medical and the medical marketplace. It also provides blood glucose monitoring systems to monitor and manage patients with diabetes. The Company markets products through these distribution. Competitors include Bayer, Becton Dickinson, LifeScan (a division of Johnson & Johnson), the MediSense and TheraSense divisions of Abbott Laboratories, and Roche.

Venture Backers

Albion Alliance, CIVC Partners, Gateway Associates, Medical Innovation Partners, Norwest Venture Partners, Parsnip River Co., Sears Investment Management Co., TA Associates, TVM Capital.

Source: Thomson Financial